학술논문
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Author
Source
In: The Lancet Haematology . (The Lancet Haematology, February 2024, 11(2):e127-e135)
Subject
Language
English
ISSN
23523026